Report Thumbnail
Product Code LP0914511483T6H
Published Date 2024/3/20
English97 PagesGlobal

Global Spatial Genomics & Transcriptomics Market Growth (Status and Outlook) 2024-2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code LP0914511483T6H◆The Mar 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/3/20
English 97 PagesGlobal

Global Spatial Genomics & Transcriptomics Market Growth (Status and Outlook) 2024-2030Pharmaceutical_LifeSciense Market



Abstract


Summary

According to our LPI (LP Information) latest study, the global Spatial Genomics & Transcriptomics market size was valued at US$ 180.2 million in 2023. With growing demand in downstream market, the Spatial Genomics & Transcriptomics is forecast to a readjusted size of US$ 279 million by 2030 with a CAGR of 6.4% during review period.
The research report highlights the growth potential of the global Spatial Genomics & Transcriptomics market. Spatial Genomics & Transcriptomics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Spatial Genomics & Transcriptomics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Spatial Genomics & Transcriptomics market.
Key Features:
The report on Spatial Genomics & Transcriptomics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Spatial Genomics & Transcriptomics market. It may include historical data, market segmentation by Type (e.g., Instruments, Consumables), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Spatial Genomics & Transcriptomics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Spatial Genomics & Transcriptomics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Spatial Genomics & Transcriptomics industry. This include advancements in Spatial Genomics & Transcriptomics technology, Spatial Genomics & Transcriptomics new entrants, Spatial Genomics & Transcriptomics new investment, and other innovations that are shaping the future of Spatial Genomics & Transcriptomics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Spatial Genomics & Transcriptomics market. It includes factors influencing customer ' purchasing decisions, preferences for Spatial Genomics & Transcriptomics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Spatial Genomics & Transcriptomics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Spatial Genomics & Transcriptomics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Spatial Genomics & Transcriptomics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Spatial Genomics & Transcriptomics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Spatial Genomics & Transcriptomics market.
Market Segmentation:
Spatial Genomics & Transcriptomics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Instruments
Consumables
Software
Segmentation by application
Academic Research
Pharmaceutical Manufacturer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NanoString Technologies
Seven Bridges Genomic
Horizon Discovery Group
CARTANA
Advanced Cell Diagnostics
10x Genomics
Dovetail Genomics
Illumina
S2 Genomics

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Spatial Genomics & Transcriptomics Market Size 2019-2030
      • 2.1.2 Spatial Genomics & Transcriptomics Market Size CAGR by Region 2019 VS 2023 VS 2030
    • 2.2 Spatial Genomics & Transcriptomics Segment by Type
      • 2.2.1 Instruments
      • 2.2.2 Consumables
      • 2.2.3 Software
    • 2.3 Spatial Genomics & Transcriptomics Market Size by Type
      • 2.3.1 Spatial Genomics & Transcriptomics Market Size CAGR by Type (2019 VS 2023 VS 2030)
      • 2.3.2 Global Spatial Genomics & Transcriptomics Market Size Market Share by Type (2019-2024)
    • 2.4 Spatial Genomics & Transcriptomics Segment by Application
      • 2.4.1 Academic Research
      • 2.4.2 Pharmaceutical Manufacturer
      • 2.4.3 Others
    • 2.5 Spatial Genomics & Transcriptomics Market Size by Application
      • 2.5.1 Spatial Genomics & Transcriptomics Market Size CAGR by Application (2019 VS 2023 VS 2030)
      • 2.5.2 Global Spatial Genomics & Transcriptomics Market Size Market Share by Application (2019-2024)
  • 3 Spatial Genomics & Transcriptomics Market Size by Player

    • 3.1 Spatial Genomics & Transcriptomics Market Size Market Share by Players
      • 3.1.1 Global Spatial Genomics & Transcriptomics Revenue by Players (2019-2024)
      • 3.1.2 Global Spatial Genomics & Transcriptomics Revenue Market Share by Players (2019-2024)
    • 3.2 Global Spatial Genomics & Transcriptomics Key Players Head office and Products Offered
    • 3.3 Market Concentration Rate Analysis
      • 3.3.1 Competition Landscape Analysis
      • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
    • 3.4 New Products and Potential Entrants
    • 3.5 Mergers & Acquisitions, Expansion
  • 4 Spatial Genomics & Transcriptomics by Regions

    • 4.1 Spatial Genomics & Transcriptomics Market Size by Regions (2019-2024)
    • 4.2 Americas Spatial Genomics & Transcriptomics Market Size Growth (2019-2024)
    • 4.3 APAC Spatial Genomics & Transcriptomics Market Size Growth (2019-2024)
    • 4.4 Europe Spatial Genomics & Transcriptomics Market Size Growth (2019-2024)
    • 4.5 Middle East & Africa Spatial Genomics & Transcriptomics Market Size Growth (2019-2024)
  • 5 Americas

    • 5.1 Americas Spatial Genomics & Transcriptomics Market Size by Country (2019-2024)
    • 5.2 Americas Spatial Genomics & Transcriptomics Market Size by Type (2019-2024)
    • 5.3 Americas Spatial Genomics & Transcriptomics Market Size by Application (2019-2024)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Spatial Genomics & Transcriptomics Market Size by Region (2019-2024)
    • 6.2 APAC Spatial Genomics & Transcriptomics Market Size by Type (2019-2024)
    • 6.3 APAC Spatial Genomics & Transcriptomics Market Size by Application (2019-2024)
    • 6.4 China
    • 6.5 Japan
    • 6.6 Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
  • 7 Europe

    • 7.1 Europe Spatial Genomics & Transcriptomics by Country (2019-2024)
    • 7.2 Europe Spatial Genomics & Transcriptomics Market Size by Type (2019-2024)
    • 7.3 Europe Spatial Genomics & Transcriptomics Market Size by Application (2019-2024)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Spatial Genomics & Transcriptomics by Region (2019-2024)
    • 8.2 Middle East & Africa Spatial Genomics & Transcriptomics Market Size by Type (2019-2024)
    • 8.3 Middle East & Africa Spatial Genomics & Transcriptomics Market Size by Application (2019-2024)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Global Spatial Genomics & Transcriptomics Market Forecast

    • 10.1 Global Spatial Genomics & Transcriptomics Forecast by Regions (2025-2030)
      • 10.1.1 Global Spatial Genomics & Transcriptomics Forecast by Regions (2025-2030)
      • 10.1.2 Americas Spatial Genomics & Transcriptomics Forecast
      • 10.1.3 APAC Spatial Genomics & Transcriptomics Forecast
      • 10.1.4 Europe Spatial Genomics & Transcriptomics Forecast
      • 10.1.5 Middle East & Africa Spatial Genomics & Transcriptomics Forecast
    • 10.2 Americas Spatial Genomics & Transcriptomics Forecast by Country (2025-2030)
      • 10.2.1 United States Spatial Genomics & Transcriptomics Market Forecast
      • 10.2.2 Canada Spatial Genomics & Transcriptomics Market Forecast
      • 10.2.3 Mexico Spatial Genomics & Transcriptomics Market Forecast
      • 10.2.4 Brazil Spatial Genomics & Transcriptomics Market Forecast
    • 10.3 APAC Spatial Genomics & Transcriptomics Forecast by Region (2025-2030)
      • 10.3.1 China Spatial Genomics & Transcriptomics Market Forecast
      • 10.3.2 Japan Spatial Genomics & Transcriptomics Market Forecast
      • 10.3.3 Korea Spatial Genomics & Transcriptomics Market Forecast
      • 10.3.4 Southeast Asia Spatial Genomics & Transcriptomics Market Forecast
      • 10.3.5 India Spatial Genomics & Transcriptomics Market Forecast
      • 10.3.6 Australia Spatial Genomics & Transcriptomics Market Forecast
    • 10.4 Europe Spatial Genomics & Transcriptomics Forecast by Country (2025-2030)
      • 10.4.1 Germany Spatial Genomics & Transcriptomics Market Forecast
      • 10.4.2 France Spatial Genomics & Transcriptomics Market Forecast
      • 10.4.3 UK Spatial Genomics & Transcriptomics Market Forecast
      • 10.4.4 Italy Spatial Genomics & Transcriptomics Market Forecast
      • 10.4.5 Russia Spatial Genomics & Transcriptomics Market Forecast
    • 10.5 Middle East & Africa Spatial Genomics & Transcriptomics Forecast by Region (2025-2030)
      • 10.5.1 Egypt Spatial Genomics & Transcriptomics Market Forecast
      • 10.5.2 South Africa Spatial Genomics & Transcriptomics Market Forecast
      • 10.5.3 Israel Spatial Genomics & Transcriptomics Market Forecast
      • 10.5.4 Turkey Spatial Genomics & Transcriptomics Market Forecast
      • 10.5.5 GCC Countries Spatial Genomics & Transcriptomics Market Forecast
    • 10.6 Global Spatial Genomics & Transcriptomics Forecast by Type (2025-2030)
    • 10.7 Global Spatial Genomics & Transcriptomics Forecast by Application (2025-2030)
  • 11 Key Players Analysis

    • 11.1 NanoString Technologies
      • 11.1.1 NanoString Technologies Company Information
      • 11.1.2 NanoString Technologies Spatial Genomics & Transcriptomics Product Offered
      • 11.1.3 NanoString Technologies Spatial Genomics & Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
      • 11.1.4 NanoString Technologies Main Business Overview
      • 11.1.5 NanoString Technologies Latest Developments
    • 11.2 Seven Bridges Genomic
      • 11.2.1 Seven Bridges Genomic Company Information
      • 11.2.2 Seven Bridges Genomic Spatial Genomics & Transcriptomics Product Offered
      • 11.2.3 Seven Bridges Genomic Spatial Genomics & Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
      • 11.2.4 Seven Bridges Genomic Main Business Overview
      • 11.2.5 Seven Bridges Genomic Latest Developments
    • 11.3 Horizon Discovery Group
      • 11.3.1 Horizon Discovery Group Company Information
      • 11.3.2 Horizon Discovery Group Spatial Genomics & Transcriptomics Product Offered
      • 11.3.3 Horizon Discovery Group Spatial Genomics & Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
      • 11.3.4 Horizon Discovery Group Main Business Overview
      • 11.3.5 Horizon Discovery Group Latest Developments
    • 11.4 CARTANA
      • 11.4.1 CARTANA Company Information
      • 11.4.2 CARTANA Spatial Genomics & Transcriptomics Product Offered
      • 11.4.3 CARTANA Spatial Genomics & Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
      • 11.4.4 CARTANA Main Business Overview
      • 11.4.5 CARTANA Latest Developments
    • 11.5 Advanced Cell Diagnostics
      • 11.5.1 Advanced Cell Diagnostics Company Information
      • 11.5.2 Advanced Cell Diagnostics Spatial Genomics & Transcriptomics Product Offered
      • 11.5.3 Advanced Cell Diagnostics Spatial Genomics & Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
      • 11.5.4 Advanced Cell Diagnostics Main Business Overview
      • 11.5.5 Advanced Cell Diagnostics Latest Developments
    • 11.6 10x Genomics
      • 11.6.1 10x Genomics Company Information
      • 11.6.2 10x Genomics Spatial Genomics & Transcriptomics Product Offered
      • 11.6.3 10x Genomics Spatial Genomics & Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
      • 11.6.4 10x Genomics Main Business Overview
      • 11.6.5 10x Genomics Latest Developments
    • 11.7 Dovetail Genomics
      • 11.7.1 Dovetail Genomics Company Information
      • 11.7.2 Dovetail Genomics Spatial Genomics & Transcriptomics Product Offered
      • 11.7.3 Dovetail Genomics Spatial Genomics & Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
      • 11.7.4 Dovetail Genomics Main Business Overview
      • 11.7.5 Dovetail Genomics Latest Developments
    • 11.8 Illumina
      • 11.8.1 Illumina Company Information
      • 11.8.2 Illumina Spatial Genomics & Transcriptomics Product Offered
      • 11.8.3 Illumina Spatial Genomics & Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
      • 11.8.4 Illumina Main Business Overview
      • 11.8.5 Illumina Latest Developments
    • 11.9 S2 Genomics
      • 11.9.1 S2 Genomics Company Information
      • 11.9.2 S2 Genomics Spatial Genomics & Transcriptomics Product Offered
      • 11.9.3 S2 Genomics Spatial Genomics & Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
      • 11.9.4 S2 Genomics Main Business Overview
      • 11.9.5 S2 Genomics Latest Developments
  • 12 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.